Intra-arterial thrombolysis using recombinant tissue plasminogen activator (r-TPA): The optimal agent, at the optimal dose?
- 1 August 1989
- journal article
- Published by Elsevier in European Journal of Vascular Surgery
- Vol. 3 (4) , 327-332
- https://doi.org/10.1016/s0950-821x(89)80069-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Low dose intra-arterial streptokinase and acylated plasminogen-streptokinase activator complex: A retrospective review of two thrombolytic regimes in recent peripheral arterial ischaemiaEuropean Journal of Vascular Surgery, 1987
- Tissue-Type Plasminogen ActivatorDrugs, 1986
- Low-dose intra-arterial streptokinase: Benefit versus riskClinical Radiology, 1985
- Low-dose direct fibrinolysis in peripheral vascular diseaseJournal of Vascular Surgery, 1984
- Differential management of acute peripheral arterial ischemiaJournal of Vascular Surgery, 1984
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Local Low-Dose Thrombolytic Therapy of Peripheral Arterial OcclusionsNew England Journal of Medicine, 1982
- Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating systemThrombosis Research, 1981
- Thrombolytic therapy in arterial thromboembolismProgress in Cardiovascular Diseases, 1979
- Treatment of chronic arterial occlusions with streptokinase.Journal of Clinical Pathology, 1972